ENTITY
Vigil Neuroscience

Vigil Neuroscience (VIGL US)

2
Analysis
Health CareUnited States
Vigil Neuroscience, Inc. operates as a biotechnology company. The Company focuses on discovering and developing novel therapeutics in basic science and human genetics of microglia. Vigil Neuroscience serves customers in the United States.
more
04 Nov 2024 23:09Issuer-paid

Biopharma Week in Review - November 4, 2024

Last week, NVO had all semaglutide dosages listed available on the FDA drug shortage list, pressuring compounded GLP-1 seller HIMS.

Logo
148 Views
Share
06 Jan 2022 00:43

Vigil Neuroscience (VIGL US) IPO: Early-Stage First-Of-Its-Class Pipeline Makes It a Risky Bet

The company plans to raise $112 million through its IPO. Vigil is a clinical-stage biotech company, whose lead drug candidate has just entered into...

Logo
334 Views
Share
x